Advanced Energy (AEIS) Q2 2023: Industrial and Medical Revenue Jumps 22% as Semiconductor Trough Hits

August 3, 2023 | By EarningsIQ Research

AEIS delivered resilient results as record industrial and medical revenue offset ongoing semiconductor softness, highlighting the benefits of its diversification strategy. Margin pressure from mix and lingering supply costs weighed on profitability, but operational streamlining and new product momentum set up a stronger margin trajectory into 2024. Management signals that design win velocity and factory consolidation will be decisive levers for future growth and margin expansion.

Summary

• Industrial and Medical Outperformance: Record revenue in these segments stabilized overall results against semiconductor weakness.
• Margin Recovery Hinges on Mix and Supply Normalization: Unfavorable product mix and component premiums pressured margins but are expected to abate by year-end.
• Operational Realignment and Design Win Pipeline: Factory consolidation and robust new product adoption position AEIS for higher-margin growth in 2024 and beyond.

Business Overview

Advanced Energy Industries (AEIS) is a provider of precision power conversion, measurement, and control solutions serving the semiconductor, industrial, medical, data center, and telecom markets. The company generates revenue by selling power supplies, plasma power generators, thermal sensors, and related services to OEMs and end users globally. Major segments include Semiconductor Equipment, Industrial and Medical, Data Center Computing, and Telecom and Networking, with the company actively pursuing a diversification strategy to reduce cyclicality.

Performance Analysis

AEIS posted total revenue of $416 million, down modestly both sequentially and year-over-year, but outperformed expectations due to record industrial and medical sales, which grew 22% YoY and now represent a rising share of the business. Semiconductor revenue, while down sharply YoY, was buoyed by strength in high-voltage and ion implant OEM demand, as well as near-record service activity, partially offsetting broader end-market correction. Data center computing remained flat sequentially, with hyperscale AI demand balancing enterprise weakness, and telecom/networking surged on improved component supply.

Gross margin compressed to 35.6%—below guidance—driven by unfavorable product mix and lingering material cost premiums, though these headwinds are expected to diminish over the next several quarters. Operating expenses were tightly managed, enabling EPS to exceed guidance despite margin pressure. Backlog fell by over $100 million sequentially as lead times normalized, signaling improved supply but also reflecting cautious customer ordering.

• Industrial and Medical Momentum: Segment posted record performance, benefiting from new product launches and expanded channel reach.
• Semiconductor Bottoming: Management believes Q2 marks the trough for this segment, with flat-to-up trajectory forecasted for the second half.
• Supply Chain Relief: Component availability improved, but select shortages (notably power MOSFETs) still limit upside in some markets.

Cash flow from operations was $24 million, impacted by tax timing, while inventory and working capital metrics showed moderate improvement. Capital expenditures remained disciplined, with major investments in new manufacturing capacity (notably Thailand) largely slated for 2024.

Executive Commentary

Strategic Positioning

1. Diversification Mitigates Cyclicality

AEIS’s push into industrial and medical markets has provided a critical buffer against semiconductor volatility. The company’s design win pipeline and new product launches in these segments are driving record sales, with management citing sustainable growth prospects and a goal of becoming the top player in medical power supplies.

2. Operational Realignment for Margin Expansion

Factory consolidation and geographic rebalancing are central to the company’s cost structure overhaul. AEIS is reducing its China footprint, expanding in Malaysia and the Philippines, and building a flagship Thailand plant (production in 2025). North American output is set to quadruple in Mexicali, all aimed at leveraging scale and improving gross margin toward a >40% target.

3. Technology Leadership and Design Win Velocity

Recent launches like the Everest RF generator and EVOS waveform generator position AEIS as a technology leader in plasma control for advanced semiconductor applications. Customer feedback is highly positive, and the company expects these platforms to drive market share gains and revenue growth from 2025 onward. The design win process, typically 12–18 months, is accelerating pipeline visibility.

4. Channel and Digital Strategy for Broader Reach

AEIS is expanding its direct and distribution channels, launching a new customer-friendly website and adding e-commerce capabilities in 2024 to better serve fragmented industrial and medical markets. This digital shift supports faster customer acquisition and product selection, especially for smaller accounts.

5. Focused Data Center Positioning

Rather than chasing volume, AEIS targets high-value, high-power applications in data centers, particularly those tied to AI infrastructure, to maintain profitability and avoid commodity competition. This strategic focus has allowed the segment to remain stable even as broader data center demand softens.

Key Considerations

This quarter underscores AEIS’s ability to navigate end-market downturns through diversification and operational discipline, but also highlights the importance of execution on factory consolidation and new product ramp timelines.

Key Considerations:

• Design Win Pipeline Depth: Record design win activity, especially in industrial/medical and next-gen semiconductor, is a key forward growth lever.
• Gross Margin Path: Margin expansion depends on mix normalization, abating supply premiums, and successful factory consolidation; execution risk remains until these factors fully materialize.
• Supply Chain Bottlenecks: While improving, select component shortages (notably power MOSFETs and microcontrollers) still limit full revenue capture and may persist into the second half.
• Capital Allocation Discipline: Major factory investments are being managed within a 4% of sales CapEx envelope, supporting future scale without overextending balance sheet risk.

Risks

Persistent semiconductor market weakness, slow normalization of component costs, and delays in new factory ramp or product adoption could pressure both revenue and margin recovery. Fragmentation in industrial and medical markets introduces channel execution risk, while macro uncertainty and customer budget constraints (especially in large medical equipment) may temper near-term demand. Ongoing supply chain tightness in key components remains a wildcard for upside realization.

Forward Outlook

For Q3 2023, AEIS guided to:

• Revenue of $415 million, plus or minus $15 million (flat sequentially)
• Gross margin improving to low to mid 36% range
• Non-GAAP EPS of $1.13, plus or minus $0.20

For full-year 2023, management maintained guidance:

• Semiconductor revenue expected to be flat to up in H2 versus H1
• Non-semiconductor markets projected to be up slightly year-over-year

Management highlighted several factors that will shape the outlook:

• Gross margin recovery as product mix normalizes and component premiums recede
• Continued operational cost discipline and ramp of new manufacturing capacity

Takeaways

AEIS’s Q2 results demonstrate the strategic value of its diversification and operational realignment, with industrial and medical strength cushioning semiconductor cyclicality. Margin recovery and future growth hinge on execution of factory consolidation, new product adoption, and supply chain normalization.

• Resilient Revenue Base: Growth in industrial and medical markets is offsetting semiconductor weakness, validating the diversification thesis.
• Margin Expansion Roadmap: Operational streamlining and product mix improvements are necessary to achieve targeted margin levels, with progress expected through 2024.
• Future Growth Drivers: Investors should watch the pace of design win conversions and the impact of new manufacturing capacity on both revenue and profitability.

Conclusion

Advanced Energy’s Q2 performance highlights a business in transition—leveraging diversification, operational discipline, and technology leadership to weather cyclical headwinds. The company’s ability to execute on its margin and growth roadmap will determine the sustainability of its current resilience and future outperformance.

Industry Read-Through

AEIS’s experience this quarter provides a clear read-through for peers in precision power, semiconductor capital equipment, and industrial automation: diversification across end-markets is proving critical for revenue stability as semiconductor cycles bottom out. Operational agility—especially factory consolidation and supply chain adaptation—remains a key differentiator in managing cost pressures and margin volatility. For the broader industry, customer appetite for new technology platforms and design win velocity are increasingly important growth drivers, while persistent component shortages highlight the ongoing need for supply chain resilience. Companies that execute on both diversification and operational excellence will be best positioned to capture upside as markets recover.

AEIS Technology Semiconductors Industrial Medical Factory Consolidation Design Wins Supply Chain